Molar teeth 
Milller Class 4 recession defects 
Pregnancy (Self-reported) 
Smoking 
Uncontrolled local or systemic diseases that affects wound healing (diabetes, autoimmune or inflammatory disorders) 
Past history of systemic steroid use over 2 weeks within the last 2 years 
Poor oral hygiene on a non-compliant individual 
Ibuprofen Allergy/interlerance 
Anticoagulant therapy (e.g. Warfarin, Plavix, etc.), will not be automatic exclusion but patients will be required to have INR test performed and have values between 2.0 to 3. Physician consultation will be requested to determine whether anticoagulant therapy can be discontinued for 3 days prior to surgery. 
Objection to blood draw or application of blood products 
Students and staff from USC Ostrow school of Dentistry will not be recruited for this study       
    

NCT03124329_exc_T1
Condition
Molar teeth
NCT03124329_exc_T2
Measurement
Milller
NCT03124329_exc_T3
Value
Class 4
NCT03124329_exc_T4
Condition
recession defects
NCT03124329_exc_T5
Condition
Pregnancy
NCT03124329_exc_T7
Condition
Smoking
NCT03124329_exc_T8
Condition
diseases local
NCT03124329_exc_T9
Condition
systemic diseases
NCT03124329_exc_T10
Qualifier
Uncontrolled
NCT03124329_exc_T11
Scope
local or systemic diseases
NCT03124329_exc_T12
Qualifier
that affects wound healing
NCT03124329_exc_T13
Condition
diabetes
NCT03124329_exc_T14
Condition
autoimmune disorders
NCT03124329_exc_T15
Condition
inflammatory disorders
NCT03124329_exc_T16
Scope
diabetes, autoimmune or inflammatory disorders
NCT03124329_exc_T17
Scope
Uncontrolled local or systemic diseases that affects wound healing
NCT03124329_exc_T18
Observation
Past history
NCT03124329_exc_T19
Drug
systemic steroid
NCT03124329_exc_T20
Temporal
over 2 weeks
NCT03124329_exc_T21
Temporal
within the last 2 years
NCT03124329_exc_T22
Condition
Poor oral hygiene
NCT03124329_exc_T23
Observation
non-compliant
NCT03124329_exc_T25
Drug
Ibuprofen
NCT03124329_exc_T26
Condition
Allergy
NCT03124329_exc_T27
Condition
interlerance
NCT03124329_exc_T28
Procedure
Anticoagulant therapy
NCT03124329_exc_T29
Drug
Warfarin
NCT03124329_exc_T30
Drug
Plavix
NCT03124329_exc_T31
Scope
Warfarin, Plavix
NCT03124329_exc_T33
Measurement
INR test
NCT03124329_exc_T34
Value
between 2.0 to 3
NCT03124329_exc_T35
Procedure
anticoagulant therapy